Congress passed another continuing resolution (CR) on November 21 – the second CR since the start of the fiscal year (FY) on October 1. The CR provides flat funding for government agencies through December 20 to avoid a government shutdown and gives Congress more time to come to an agreement on a final FY 2020 appropriations package.
Short-term spending bills make it difficult for the National Institutes of Health (NIH) – as well as the institutions and scientists it supports – to effectively plan for research projects.
ASCO is asking Congress to pass a full FY 2020 funding bill with the highest possible funding increase for the NIH, along with a proportional increase for the National Cancer Institute (NCI). We are thankful to appropriators and Congressional leadership that NIH’s budget has increased by 29% over the last four years, but we have not caught up to years of stagnant funding and NCI’s budget has not kept pace. Flat funding and long-term CR’s create inefficiencies and uncertainty for scientists across the country.
Joining fellow members of the One Voice Against Cancer Coalition (OVAC), ASCO sent a letter to leaders of the House and Senate Appropriations Committees thanking them for their commitment to cancer research, outlining the importance of investing in the NIH and NCI, and calling on them to continue support of cancer research in the final FY 2020 funding package.
Stay up to date on federal funding and other oncology policy issues by following along with ASCO in Action.